commercialisation around the corner

We should start seeing this stock starting to firm in price with commercialisation around the corner.

I would like to see a summary from the company re: timetable for commercialisation of various products.
At this stage I would expect sales to commence first in Australia and Europe as approvals have already been received. This will be followed by the U.S.A. where FDA approval should not be too far away.

The potential revenue flow from the personal wheezometer and other associated products could be huge. Another factor to ponder is that I think that KSX might be a potential takeover target by one of the World's major players.